M K Proteins Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
M K Proteins Limited reported audited standalone financial results for FY26 ending March 31, 2026. Revenue from operations grew significantly to Rs. 38,287.52 Lakhs from Rs. 26,770.60 Lakhs in the prior year, representing ~43% year-on-year growth driven by the vegetable refined oil business. However, profit after tax declined to Rs. 682.90 Lakhs from Rs. 839.74 Lakhs, a drop of ~18.7%, indicating margin compression despite higher sales. Finance costs increased to Rs. 185.20 Lakhs from Rs. 110.50 Lakhs. EPS declined to Rs. 0.18 from Rs. 0.22. Total assets stood at Rs. 13,119.70 Lakhs with equity of Rs. 7,630.02 Lakhs. Outstanding borrowings reduced slightly to Rs. 36.19 Crores from Rs. 37.75 Crores. The auditor issued an unmodified (clean) opinion with no going concern issues. Related party transactions for H2 FY26 were disclosed separately via XBRL filing.
Strong top-line growth of ~43% was offset by ~19% decline in net profit, reflecting margin pressure from higher input or finance costs. The clean audit opinion is positive, but declining PAT and EPS may concern investors focused on profitability.